XM无法为美国居民提供服务。

XM无法为美国居民提供服务。
B
B

BayerAG

市场新闻

Reuters - 7小时前

Coca-Cola plans to invest $1 billion in Nigeria operations, presidency says

Coca-Cola plans to invest $1 billion in Nigeria operations, presidency says ABUJA, Sept 19 (Reuters) - Coca-Cola plans to invest $1 billion in its Nigeria operations over the next five years, the country's presidency said after a meeting between President Bola Tinubu and senior executives of the soft drinks maker on Thursday. Tinubu met John Murphy, president and chief financial officer of Coca‑Cola KO.N , Zoran Bogdanovic, CEO of Coca-Cola HBC CCH.L - one of Coca-Cola's many bottlers worldwid
B
G
C
Reuters - 2天前

BASF to prepare agricultural business for IPO, Bloomberg reports

UPDATE 3-BASF to prepare agricultural business for IPO, Bloomberg reports Adds details on new CEO in paragraph 12, on batteries business in paragraph 13 FRANKFURT, Sept 18 (Reuters) - BASF BASFn.DE plans to prepare its agricultural chemicals business for an initial public offering in the next few years as part of restructuring measures set to be announced by the group this month, Bloomberg News reported on Wednesday.
B
B
C
Reuters - 3天前

Bayer, others defeat US farmers' chemical price-fixing lawsuit

Bayer, others defeat US farmers' chemical price-fixing lawsuit By Mike Scarcella Sept 16 (Reuters) - A U.S. judge has dismissed a lawsuit accusing agriculture giants Bayer, Corteva, Syngenta and others of conspiring with wholesalers and retail outlets to fix prices for seeds and crop protection chemicals, causing farmers to pay higher prices. St. Louis-based U.S.
B
B
C
Reuters - 4天前

Bayer AG Says Darolutamide Plus Adt Significantly Reduced Risk Of Radiological Progression Or Death Compared To Placebo Plus Adt In Patients With Mhspc

BRIEF-Bayer AG Says Darolutamide Plus Adt Significantly Reduced Risk Of Radiological Progression Or Death Compared To Placebo Plus Adt In Patients With Mhspc Bayer AG BAYGn.DE : BAYER AG SAYS DAROLUTAMIDE PLUS ADT SIGNIFICANTLY REDUCED RISK OF RADIOLOGICAL PROGRESSION OR DEATH COMPARED TO PLACEBO PLUS ADT IN PATIENTS WITH MHSPC Source text for Eiko
B
Reuters - 1周前

Jury rules in favor of Bayer's Monsanto in Philadelphia trial over Roundup

Jury rules in favor of Bayer's Monsanto in Philadelphia trial over Roundup Sept 11 (Reuters) - Bayer's BAYGn.DE Monsanto unit said on Wednesday that a Philadelphia Court jury reached a verdict in the Young Roundup product liability trial in their favor. Bayer bought Monsanto for $63 billion in 2018, and has faced extensive and costly litigation over whether Monsanto's Roundup weed killer causes cancer.
B
Reuters - 1周前

Bayer Says Jury Finds In Favor Of Monsanto In Philadelphia Trial

BRIEF-Bayer Says Jury Finds In Favor Of Monsanto In Philadelphia Trial Sept 11 (Reuters) - Bayer AG BAYGn.DE : JURY FINDS IN FAVOR OF MONSANTO IN PHILADELPHIA TRIAL BAYER AG: JURY REACHED VERDICT IN YOUNG ROUNDUP PRODUCT LIABILITY TRIAL BEFORE JUDGE ANGELO FOGLIETTA IN PHILADELPHIA COURT OF COMMON PLEAS. BAYER AG - WILL CONTINUE SUPPORTING LEGISLAT
B
Reuters - 1周前

Bayer Issues 750 Million Euro Hybrid Bond

BRIEF-Bayer Issues 750 Million Euro Hybrid Bond Sept 10 (Reuters) - BAYER AG BAYGn.DE : ISSUES 750 MILLION EURO HYBRID BOND SINGLE TRANCHE WITH A NON-CALL PERIOD OF 5.25 YEARS, COMBINED WITH A TENDER OFFER FOR ONE OF BAYER’S EXISTING HYBRID BONDS BAYER INTENDS TO LIST THE HYBRID BONDS ON THE LUXEMBOURG STOCK EXCHANGE THE PROCEEDS WILL BE USED FOR
B
Reuters - 1周前

European companies cut jobs as economy sputters

RPT-FACTBOX-European companies cut jobs as economy sputters Repeats with no changes to text to add 'Factbox' tag in headline Sept 10 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some of the layoffs announced since the start of June: BANKS * DNB DNB.OL : The Norwegian lender said on Sept.
B
I
U
V
U
Reuters - 1周前

European companies cut jobs as economy sputters

European companies cut jobs as economy sputters Adds DNB Sept 10 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some of the layoffs announced since the start of June: BANKS * DNB DNB.OL : The Norwegian lender said on Sept. 10 it would cut the equivalent of 500 full-time jobs over the next six months, as it prepares for lower interest rates and tougher competition ahead.
B
I
U
V
U
Reuters - 1周前

Bayer: Analysis From HF Reveals Patients Receiving Finerenone Have Reduced Risk Of New-Onset Diabetes

BRIEF-Bayer: Analysis From FINEARTS-HF Reveals Patients Receiving Finerenone Have Reduced Risk Of New-Onset Diabetes Sept 10 (Reuters) - BAYER AG BAYGn.DE : NEW SUBGROUP ANALYSIS FROM FINEARTS-HF REVEALED PATIENTS WITH HEART FAILURE AND A LEFT VENTRICULAR EJECTION FRACTION OF ≥40% RECEIVING FINERENONE HAD A REDUCED RISK OF NEW-ONSET DIABETES Furt
B
Reuters - 1周前

Bayer Reports Preliminary Efficacy Results for BAY 2927088 in Phase I/ 01 Study

BRIEF-Bayer Reports Preliminary Efficacy Results for BAY 2927088 in Phase I/ II SOHO-01 Study Sept 10 (Reuters) - BAYER AG BAYGn.DE : SAID ON MONDAY: NEW RESULTS FOR INVESTIGATIONAL AGENT BAY 2927088 IN HER2-MUTANT NON-SMALL CELL LUNG CANCER PRESENTED ENCOURAGING RESULTS FROM EXPANSION PART OF ONGOING PHASE I/II SOHO-01 STUDY EVALUATING THE SAFETY
B
Reuters - 2周前

Bayer's Eye Drug Pre-Filled Syringes Approved In EU

BRIEF-Bayer's Eye Drug Pre-Filled Syringes Approved In EU Sept 9 (Reuters) - Bayer AG BAYGn.DE : EYLEA™ 8 MG PRE-FILLED SYRINGE APPROVED IN EU GERMANY WILL BE ONE OF FIRST MARKETS TO LAUNCH NEW PRE-FILLED SYRINGE Further company coverage: BAYGn.DE (Gdansk Newsroom)
B
Reuters - 2周前

Bayer to Present New Prostate Cancer Data and Continued Oncology Portfolio

BRIEF-Bayer to Present New Prostate Cancer Data and Continued Oncology Portfolio Sept 4 (Reuters) - BAYER AG BAYGn.DE WILL PRESENT PRIMARY RESULTS FROM THE PHASE III ARANOTE TRIAL IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) FOR NUBEQA(®)(DAROLUTAMIDE) AS A LATE-BREAKING ORAL PRESENTATION WILL PRESENT PRIMARY RESULTS FROM THE EUROPEAN O
B
Reuters - 2周前

VW row flags Germany’s creaking corporate model

BREAKINGVIEWS-VW row flags Germany’s creaking corporate model The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Pierre Briancon BERLIN, Sept 5 (Reuters Breakingviews) - A company whose chief financial officer says it only has “one, maybe two” years to turn around its core brand must have done something wrong.
B
B
T
V
Reuters - 2周前

Bayer To Unveil New Data From Its Phase III Oasis 3 Long-Term Study Of Elinzanetant

BRIEF-Bayer To Unveil New Data From Its Phase III Oasis 3 Long-Term Study Of Elinzanetant Sept 4 (Reuters) - BAYER AG BAYGn.DE : TO UNVEIL NEW DATA FROM ITS PHASE III OASIS 3 LONG-TERM STUDY OF ELINZANETANT IN TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE BAYER WILL PRESENT DETAILED RESULTS SEPTEMBER 10 - 14 Further company coverage: [B
B
Reuters - 2周前

European companies cut jobs as economy sputters

FACTBOX-European companies cut jobs as economy sputters Adds Telia Sept 4 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some of the layoffs announced since the start of April: BANKS * TSB: The British bank owned by Spain's Sabadell SABE.MC is seeking 250 job cuts, its spokesperson and employee union said on May 8. INDUSTRIALS AND ENGINEERING * PKP CARGO PKPP.WA : Poland's largest freight co
B
B
B
C
I
N
T
T
U
V
B
U
Reuters - 2周前

US will still pay at least twice as much after negotiating drug prices

UPDATE 1-US will still pay at least twice as much after negotiating drug prices U.S. pays higher drug prices, gets priority access Medicare's negotiated prices most significant for drugs with little competition Goal is to balance affordability and innovation Updates first graphic to align colors representing countries with second graphic By Deena Beasley Sept 3 (Reuters) - The U.S.
A
A
B
N
P
Reuters - 2周前

Bayer: Bluerock Gets FDA Clearance Of Application For Photoreceptor Diseases Treatment

BRIEF-Bayer: Bluerock Gets FDA Clearance Of Application For Photoreceptor Diseases Treatment Sept 3 (Reuters) - Bayer AG BAYGn.DE : BLUEROCK THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR INVESTIGATIONAL IPSC-DERIVED CELL THERAPY OPCT-001 FOR TREATMENT OF PRIMARY PHOTORECEPTOR DISEASES Further company coverage: [BAYGn.DE] (Gdansk Newsr
B
Reuters - 2周前

US will still pay at least twice as much after negotiating drug prices

ANALYSIS-US will still pay at least twice as much after negotiating drug prices U.S. pays higher drug prices, gets priority access Medicare's negotiated prices most significant for drugs with little competition Goal is to balance affordability and innovation By Deena Beasley Sept 3 (Reuters) - The U.S. government's first-ever negotiated prices for prescription drugs are still on average more than double, and in some cases five times, what drugmakers have agreed to in four other high-income count
A
A
B
N
P
Reuters - 3周前

Bayer rises after positive kidney drug study in heart failure

CORRECTED-BUZZ-Bayer rises after positive kidney drug study in heart failure Corrects trial name in 2nd bullet; updates share performance in 1st and 5th bullet ** Shares in Bayer BAYGn.DE rise 0.6% after the German firm said its kidney drug Kerendia helped patients avoid complications from a common form of heart failure ** The late-stage FINEARTS-H
B
G

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。

风险提示： 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明。